Recently, provinces and cities across China have been hit by strong cold air, leading to a peak period of respiratory diseases. The number of medical visitors in hospitals in many regions has surged, bringing enormous diagnosis and treatment pressure to medical institutions at all levels.
On December 24, the National Health Commission held a press conference to introduce the prevention and control of winter respiratory diseases in China.

At the press conference, Peng Zhibin, Director of the Respiratory Infectious Disease Office of the Infectious Disease Management Department of the Chinese Center for Disease Control and Prevention, stated: Overall, the current acute respiratory diseases are dominated by influenza viruses, with the co-circulation of various other pathogens. Among them, influenza activity is at a high level but slightly declining; Mycoplasma pneumoniae, adenovirus, and respiratory syncytial virus activities show fluctuating changes; and COVID-19 activity is at the lowest level since the beginning of this year.
Different types of respiratory pathogens may cause different diseases, and the transmission modes and treatment methods of pathogens also vary. Rapid typing through nucleic acid detection can accurately identify the specific pathogens of infection, help doctors formulate more precise treatment plans, and improve the level of individualized treatment for patients.
Amid this wave of respiratory pathogen infections, e-commerce model-based respiratory pathogen testing has emerged. This cross-border cooperation model can quickly and effectively help identify infected persons, isolate sources of infection, and slow down virus transmission. In the post-COVID era, nucleic acid testing has also been "competed" to a new height, with major reagent manufacturers joining the queue of rapid reagent research and development. The emergence of this e-commerce + testing model in the post-COVID era has gradually highlighted the advantages of small-throughput rapid fluorescent quantitative PCR instruments, which are highly consistent with the market demand for rapid, accurate and point-of-care testing.
Archimed Mini
Assists in Rapid and Accurate Detection of Respiratory Pathogens
Archimed Mini series instruments are rapid and portable fluorescent quantitative PCR instruments meticulously built by Rocgene. This series of instruments has an ultra-high temperature rise and fall rate of up to ≥11℃/s, ensuring rapid detection. With rapid detection kits, the fastest detection time can be shortened to within 25 minutes; 16 detection throughput enables on-demand sample testing; 4-color fluorescence channels are compatible with most detection reagents on the market; the well-to-well uniformity and accuracy can reach ±0.15℃, effectively ensuring detection rate and accuracy.
Product Features
Archimed Mini 16


Archimed Mini Pro


Archimed Mini+Respiratory Pathogen Detection
Application Demonstration
✥ Company A's Influenza A/B and RSV Detection Kit + actual positive sample test results, total running time: 25 min 16s.

✥ Company B's Influenza A/B Detection Reagent + positive reference, total running time: 28 min 34s.

✥ Company S's Upper Respiratory Tract 6 Detection Reagent + low-concentration standard - limit of detection rate test, total running time: 33 min 1s, and the reagent limit of detection rate is nearly 100%.

✥ Company S's Upper Respiratory Tract 6 Detection Reagent + actual sample test
① Colleague Xiao L in the company felt unwell and took the test, which showed positive for Influenza B.

② Colleague Xiao Z in the company had a fever for 3 days and tested positive for Influenza A/B.

③ Colleague Xiao Q in the company had a fever for 2 days and general fatigue, and tested positive for Influenza A/B and RSV.

With reference to the test results, all colleagues recovered quickly after symptomatic treatment.
Archimed Mini series instruments, starting from the micro level. For respiratory tract testing, early detection and early treatment, escort your health!
For more instrument details, welcome to inquire,
We sincerely look forward to cooperating with you!
06
16
08
18

